WRF
AGN

Waddell & Reed Financial’s Allergan plc AGN Stock Holding History

Waddell & Reed Financial’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,000
Closed -$3.81M – 578
2018
Q3 		$3.81M Buy
+20,000
New +$3.67M 0.01% 498

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Waddell & Reed Financial's AGN Position: Q4 2018 in Review

Waddell & Reed Financial sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 65,000 shares — an estimated $12.4M sold.

Waddell & Reed Financial first reported a position in AGN in Q4 2014 and held it in 16 quarters. The position peaked at $1.42B in Q1 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Waddell & Reed Financial reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Waddell & Reed Financial sold 65,000 Allergan plc shares in Q4 2018, an estimated $12.4M.
  • Waddell & Reed Financial first reported a position in Allergan plc in Q4 2014 and held it in 16 quarters.
  • Waddell & Reed Financial's Allergan plc position peaked at $1.42B in Q1 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Waddell & Reed Financial's 13F filing for Q4 2018, filed 14 Feb 2019.